Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial

Zhang, 2016, Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies, Am J Clin Nutr, 103, 330, 10.3945/ajcn.115.124081

Yassine, 2016, Association of serum docosahexaenoic acid with cerebral amyloidosis, JAMA Neurol, 73, 1208, 10.1001/jamaneurol.2016.1924

Calon, 2004, Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model, Neuron, 43, 633, 10.1016/j.neuron.2004.08.013

Bouwens MvdR, 2009, Fish-oil supplementation induces antiinflammatory gene expression profiles in human blood mononuclear cells, Am J Clin Nutr, 90, 415, 10.3945/ajcn.2009.27680

Hooijmans, 2007, Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD), Neurobiol Dis, 28, 16, 10.1016/j.nbd.2007.06.007

de Magalhães, 2016, Fish oil supplements, longevity, and aging, Aging, 8, 1578, 10.18632/aging.101021

Swanson, 2012, Omega-3 fatty acids EPA and DHA: health benefits throughout life, Adv Nutr, 3, 1, 10.3945/an.111.000893

Funk, 2001, Prostaglandins and leukotrienes advances in eicosanoid biology, Science, 294, 1871, 10.1126/science.294.5548.1871

Thomas, 2015, Omega-3 fatty acids in early prevention of inflammatory neurodegenerative disease: a focus on Alzheimer's disease, Biomed Res Int, 2015, 172801, 10.1155/2015/172801

Itakura, 2011, Relationships between plasma fatty acid composition and coronary artery disease, J Atheroscler Thromb, 18, 99, 10.5551/jat.5876

Yassine, 2017, Association of docosahexaenoic acid supplementation with alzheimer disease stage in apolipoprotein E epsilon4 carriers: a review, JAMA Neurol, 10.1001/jamaneurol.2016.4899

Sydenham, 2013, Omega 3 fatty acid for the prevention of cognitive decline and dementia, Cochrane Database Syst Rev

Yi, 2018, Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism, Alzheimers Res Ther, 10, 84, 10.1186/s13195-018-0411-x

Head, 2012, Exercise engagement as a moderator of the effects of APOE genotype on amyloid deposition, Arch Neurol, 69, 636, 10.1001/archneurol.2011.845

Chouinard-Watkins, 2013, Disturbance in uniformly 13C-labelled DHA metabolism in elderly human subjects carrying the apoE epsilon4 allele, Br J Nutr, 110, 1751, 10.1017/S0007114513001268

Chouinard-Watkins, 2014, Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?, Nutrients, 6, 4452, 10.3390/nu6104452

Yassine, 2017, DHA brain uptake and APOE4 status: a PET study with [1-11 C]-DHA, Alzheimers Res Ther, 9, 23, 10.1186/s13195-017-0250-1

Freund Levi, 2014, Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study, J Intern Med, 275, 428, 10.1111/joim.12166

Khot, 2014, Expression of genes encoding enzymes involved in the one carbon cycle in rat placenta is determined by maternal micronutrients (folic acid, vitamin B12) and omega-3 fatty acids, Biomed Res Int, 2014, 10.1155/2014/613078

Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's Dement: J Alzheimer's Assoc, 7, 270, 10.1016/j.jalz.2011.03.008

Jimenez, 2015, Breast milk from women living near Lake Malawi is high in docosahexaenoic acid and arachidonic acid, Prostaglandins Leukot Essent Fatty Acids, 95, 71, 10.1016/j.plefa.2014.12.002

Rawat, 2019, ApoE4 alters ABCA1 membrane trafficking in astrocytes, J Neurosci, 39, 9611, 10.1523/JNEUROSCI.1400-19.2019

Nation, 2019, Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction, Nat Med, 25, 270, 10.1038/s41591-018-0297-y

Yassine, 2016, The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease, Alzheimers Res Ther, 8, 25, 10.1186/s13195-016-0194-x

Bazinet, 2020, Brain eicosapentaenoic acid metabolism as a lead for novel therapeutics in major depression, Brain Behav Immun, 85, 21, 10.1016/j.bbi.2019.07.001

Dyall, 2015, Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA, Front Aging Neurosci, 7, 52, 10.3389/fnagi.2015.00052

Dong, 2018, Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1β-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons, BMC Neurosci, 19, 52, 10.1186/s12868-018-0455-7

Kohli, 2009, Resolvins and protectins: mediating solutions to inflammation, Br J Pharmacol, 158, 960, 10.1111/j.1476-5381.2009.00290.x

Tassoni, 2008, The role of eicosanoids in the brain, Asia Pac J Clin Nutr, 17, 220

Tao, 2018, Association of chronic low-grade inflammation with risk of Alzheimer Disease in ApoE4 carriers, JAMA Netw Open, 1, 10.1001/jamanetworkopen.2018.3597

Arterburn, 2006, Distribution, interconversion, and dose response of n-3 fatty acids in humans, Am. J. Clin. Nutr., 83, 1467S, 10.1093/ajcn/83.6.1467S

Umhau, 2009, Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography, J Lipid Res, 50, 1259, 10.1194/jlr.M800530-JLR200

Yassine, 2016, The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease, Alzheimer's Rea Therapy, 8, 25, 10.1186/s13195-016-0194-x

Jernerén, 2015, Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial, Am J Clin Nutr, 102, 215, 10.3945/ajcn.114.103283

Jernerén, 2019, Homocysteine status modifies the treatment effect of omega-3 fatty acids on cognition in a randomized clinical trial in mild to moderate Alzheimer's disease: the OmegAD study, J Alzheimers Dis, 69, 189, 10.3233/JAD-181148

Flock, 2013, Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial, J Am Heart Assoc, 2, 10.1161/JAHA.113.000513

Bhatt, 2019, Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia, N Engl J Med, 380, 11, 10.1056/NEJMoa1812792

Bhatt, 2017, Rationale and design of REDUCE-IT: reduction of cardiovascular events with icosapent ethyl-intervention trial, Clin Cardiol, 40, 138, 10.1002/clc.22692

Andrieu, 2017, Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial, Lancet Neurol, 16, 377, 10.1016/S1474-4422(17)30040-6

Cukierman-Yaffe T., Bosch J., Diaz R., Dyal L., Hancu N., Hildebrandt P., et al. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial. Lancet Diabetes Endocrinol 2014;2(7):562–72.

Manson, 2018, Marine n−3 fatty acids and prevention of cardiovascular disease and cancer, N Engl J Med, 380, 23, 10.1056/NEJMoa1811403

Chocano-Bedoya, 2019, DO-HEALTH: vitamin D3-omega-3-home exercise-healthy aging and longevity trial—dietary patterns in five European countries, 3

Sydenham, 2012, Omega 3 fatty acid for the prevention of cognitive decline and dementia, Sao Paulo Med J, 130, 419, 10.1590/S1516-31802012000600013

Yurko-Mauro, 2015, Docosahexaenoic acid and adult memory: a systematic review and meta-analysis, PLoS One, 10, 10.1371/journal.pone.0120391

Eriksdotter, 2015, Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients during oral omega-3 fatty acid supplementation: the OmegAD study, J Alzheimers Dis, 48, 805, 10.3233/JAD-150102

Soininen H., Solomon A., Visser P.J., Hendrix S.B., Blennow K., Kivipelto M., et al. 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial. Lancet Neurol 2017;16(12):965–75.

Hooijmans, 2012, The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis, J Alzheimer's Dis, 28, 191, 10.3233/JAD-2011-111217

Schuchardt, 2013, Bioavailability of long-chain omega-3 fatty acids, Prostaglandins Leukot Essent Fatty Acids, 89, 1, 10.1016/j.plefa.2013.03.010

Liu, 2014, Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets, J Lipid Res, 55, 531, 10.1194/jlr.M045930

Liu, 2015, Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease, Brain Res, 1597, 220, 10.1016/j.brainres.2014.11.059

Nguyen, 2014, Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid, Nature, 509, 503, 10.1038/nature13241

Patrick, 2019, Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease, Faseb J, 33, 1554, 10.1096/fj.201801412R

Metherel, 2017, Retroconversion is a minor contributor to increases in eicosapentaenoic acid following docosahexaenoic acid feeding as determined by compound specific isotope analysis in rat liver, Nutr Metab, 14, 75, 10.1186/s12986-017-0230-2

Conquer, 1997, Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores, Lipids, 32, 341, 10.1007/s11745-997-0043-y

Grønn, 1991, Peroxisomal retroconversion of docosahexaenoic acid (22:6(n−3)) to eicosapentaenoic acid (20:5(n−3)) studied in isolated rat liver cells, Biochim Biophys Acta (BBA) – Lipids Lipid Metab, 1081, 85, 10.1016/0005-2760(91)90254-F

Champeil-Potokar, 2016, Docosahexaenoic acid (DHA) prevents corticosterone-induced changes in astrocyte morphology and function, J Neurochem, 136, 1155, 10.1111/jnc.13510

Chouinard-Watkins, 2014, Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?, Nutrients, 6, 4452, 10.3390/nu6104452

Fanelli, 2013, Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease, Mol Neurodegener, 8, 8, 10.1186/1750-1326-8-8

Yassine, 2016, Association of serum docosahexaenoic acid with cerebral amyloidosis, JAMA Neurol, 73, 1208, 10.1001/jamaneurol.2016.1924

Eckert, 2011, Liposome-incorporated DHA increases neuronal survival by enhancing non-amyloidogenic APP processing, Biochim Biophys Acta, 1808, 236, 10.1016/j.bbamem.2010.10.014

Grimm, 2011, Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms, J Biol Chem, 286, 14028, 10.1074/jbc.M110.182329